alexa Bioequivalence-innovations | OMICS International | Journal Of Bioequivalence And Bioavailability

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Bioequivalence Innovations

The property wherein 2 medicines with equivalent active components (as a brand-name drug and its common equivalent) or 2 distinct drugs dosage forms (as tablet and oral suspension) of the same drug have identical bioavailability and generate the similar impact at the site of physiological activity. Innovations are new idea, device or process. Innovations are the application of better solutions that meet new requirements, inarticulated needs or existing market needs. It is proficient through more effective products, processes, services, technologies, or new ideas that are readily available to markets, governments and society. Innovations are something original and novel, as a significant, new that “breaks into” the market or society.
  • Share this page
  • Facebook
  • Twitter
  • LinkedIn
  • Google+
  • Pinterest
  • Blogger

Last date updated on September, 2014

Top